25 Mar Contract manufacturing services agreement signed with Yourgene Health Plc Additional manufacturing capacity to support demand for Novacyt’s COVID-19 diagnostic test

Posted at 07:08h in Board, Novacyt Group, Products by

Paris, France and Camberley, UK – 25 March 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that, further to the notification on 20 March 2020, the Company has signed an agreement for certain contract manufacturing services with Yourgene Health Plc (“Yourgene”) (AIM: YGEN), an international molecular diagnostics group. Yourgene will support Novacyt in the production of the COVID-19 diagnostic test developed by Primerdesign, the Company’s molecular diagnostics division.

https://novacyt.com/wp-content/uploads/2020/03/Novacyt-YourGene-PR-ENGLISH-25.03.20-final.pdf